ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,000 | -20.0% | 206 | 0.0% | 0.01% | +200.0% |
| Q1 2022 | $15,000 | -16.7% | 206 | -1.0% | 0.00% | -25.0% |
| Q4 2021 | $18,000 | -5.3% | 208 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $19,000 | -5.0% | 206 | -1.0% | 0.00% | -20.0% |
| Q2 2021 | $20,000 | -16.7% | 208 | -3.3% | 0.01% | -16.7% |
| Q1 2021 | $24,000 | -68.0% | 215 | -60.2% | 0.01% | -57.1% |
| Q4 2020 | $75,000 | +70.5% | 540 | -0.2% | 0.01% | +55.6% |
| Q3 2020 | $44,000 | +7.3% | 541 | +2.5% | 0.01% | 0.0% |
| Q2 2020 | $41,000 | +78.3% | 528 | +3.9% | 0.01% | +50.0% |
| Q1 2020 | $23,000 | +64.3% | 508 | +52.1% | 0.01% | +100.0% |
| Q4 2019 | $14,000 | +600.0% | 334 | +882.4% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 34 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $3,000 | +50.0% | 34 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 34 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 34 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 34 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 34 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 34 | -97.7% | 0.00% | – |
| Q4 2017 | $2,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |